DHB(1-Testosterone cypionate ,Dihydrobodenone) Oil Steroids Injectable 100mg/ml

Description

Testosterone Cypionate Long-Ester Injectable Androgen Research

Chemical Properties

• CAS Number: 65-06-5 (Parent Molecule)
• Molecular Formula: C19H28O2
• Molecular Weight: 288.42 g/mol
• Appearance: Clear to pale amber viscous solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Appearance: Clear, pale yellow to amber viscous solution
• Solubility: Optimized in organic carrier lipids including Ethyl Oleate and Miglyol 840

Pharmacodynamics

The pharmacology of DHB Oil is defined by its structural inability to undergo aromatization and its superior binding affinity compared to native testosterone. Dihydroboldenone binds to the androgen receptor with a Ki value significantly lower than that of testosterone, ensuring rapid nuclear translocation and gene transcription. The 5α-reduced steroid nucleus prevents estrogenic signaling, effectively eliminating the risk of fluid retention or mammary tissue proliferation in research models. Furthermore, DHB signaling enhances nitrogen retention by up-regulating the efficiency of amino acid transport across the sarcolemma. Quantitative data indicates a terminal half-life of approximately 8 days when utilizing a cypionate ester delivery system, allowing for stable plasma concentrations over prolonged research durations. Binding kinetics show that the 1-ene double bond significantly increases the molecule’s resistance to metabolic deactivation in skeletal muscle.

Product Profile

DHB Oil (Dihydroboldenone), chemically identified as 1-Testosterone, is a highly potent 5α-reduced derivative of boldenone that functions as a high-affinity agonist for the nuclear androgen receptor (AR). Dihydroboldenone lacks the 4,5-double bond of traditional testosterone, which prevents its conversion into estrogenic metabolites via the aromatase enzyme. Researchers prioritize this compound for investigating localized myogenic signaling and the modulation of metabolic rate in advanced biological systems. Unlike its parent compound EQUIPOISE, DHB provides a more direct anabolic stimulus without the necessity of further enzymatic reduction.

Known Effects

• Dry Tissue Accrual: Research models indicate steady increases in lean muscle mass characterized by a complete absence of subcutaneous water retention.
• Enhanced Vascularity: Based on community feedback, effects include a marked increase in peripheral vascularity and muscular hardness within 14 days of administration.
• Metabolic Rate Acceleration: Study data demonstrates a significant rise in basal metabolic rate and core body temperature during the active phase.
• Strength Performance: The typical user-reported experience involves a sharp trajectory in maximal force production, particularly in resistance-trained models.
• Red Blood Cell Modulation: Research models show a dose-dependent increase in erythropoiesis, improving systemic oxygen transport efficiency.

Key Points:
DHB Oil remains a premier research tool for studying pure anabolic signaling and tissue remodeling without the interference of estrogenic or progestogenic activity.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.